Marla Francisca Dos Santos, Rita Nely Vilar Furtado, Monique Sayuri Konai, Mario Luiz Vieira Castiglioni, Renata Rosa Marchetti, Constancia Pagano Gonçalves Silva, Jamil Natour
Index: Clin. Rheumatol. 30(1) , 77-85, (2011)
Full Text: HTML
The aim of the present study was to investigate the long-term effectiveness of and tolerance to Yttrium-90 and Samarium-153-particulate hydroxyapatite radiation synovectomy in patients with rheumatoid arthritis (RA) and chronic knee synovitis. Eight-four patients (90 knees) with chronic knee synovitis and RA (according to the American College of Rheumatology criteria) participated in a controlled, double-blinded trial. Patients were randomized to receive an intra-articular injection with either 5 mCi Yttrium-90 plus 40 mg of triamcinolone hexacetonide (Y/TH Group), 15 mCi Samarium-153 hydroxyapatite plus 40 mg of triamcinolone hexacetonide (Sm/TH Group), or 40 mg triamcinolone hexacetonide alone (Control Group). Blinded examination at baseline, 1, 4, 12, 32, and 48 weeks post-intervention included a visual analog scale for joint pain and swelling, morning stiffness, range of motion, knee circumference, Likert scale, percentage of improvement, Stanford Health Assessment Questionnaire, Lequesne index, use of non-steroidal anti-inflammatory drugs and corticosteroids, events and adverse effects, calls to the physician, and hospital visits. There were three withdrawals prior to the injections. Regarding the pain, there was a significantly better response in the Y/TH Group versus the Sm/TH Group at T1 (p = 0.025) and versus TH alone at T48 (p = 0.026). The Sm/TH group had more adverse effects (p = 0.042), but these were mild and transitory. For the pain parameter alone, Yttrium-90 radiosynovectomy associated to TH proved superior to Samarium-153 hydroxyapatite radiosynovectomy associated to TH at T1 and to synovectomy with TH at T48. No other statistically significant inter-group differences were detected.
Structure | Name/CAS No. | Molecular Formula | Articles |
---|---|---|---|
![]() |
Triamcinolone hexacetonide
CAS:5611-51-8 |
C30H41FO7 |
Impact of local steroid or statin treatment of experimental ...
2015-01-01 [Am. J. Orthod. Dentofacial Orthop. 147(1) , 80-8, (2015)] |
Effectiveness of intra-articular injection in wrist joints a...
2015-02-01 [Am. J. Phys. Med. Rehabil. 94(2) , 131-8, (2015)] |
Does modern treatment of early rheumatoid arthritis reduce t...
2013-01-01 [Scand. J. Rheumatol. 42(2) , 163-4, (2013)] |
Effect of simvastatin injections on temporomandibular joint ...
2013-05-01 [J. Oral Maxillofac. Surg. 71(5) , 846-53, (2013)] |
Delineating the role of multiple intraarticular corticostero...
2013-07-01 [Arthritis Care Res. (Hoboken.) 65(7) , 1112-20, (2013)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved